Navigation Links
Bioenergy D-Ribose Achieves Highest Safety Standard
Date:11/20/2008

MINNEAPOLIS, Nov. 20 /PRNewswire/ -- Integrative life science company Bioenergy, Inc. has achieved GRAS status (generally recognized as safe) from the U.S. Food and Drug Administration (FDA) for its core energy nutrient D-ribose, a naturally occurring monosaccharide the body uses to stimulate the synthesis of adenosine triphosphate (ATP) -- an essential energy compound.

"The FDA's written response that it has reviewed the submitted safety evidence and has no questions about the GRAS determination for D-ribose is the government's highest recognition of a food ingredient for safety and purity," said Raj Khankari, Ph.D., CEO of Bioenergy, Inc. The company has held "self-affirmed" GRAS status for years. "Today, we are gratified that the FDA has officially validated our assessment."

"The FDA's 'no questions letter' signals to the major food and beverage manufacturers that we have invested all the resources possible to guarantee the quality and safety of our D-ribose products for the benefit of customers and consumers."

Bioenergy has amassed a large body of scientific literature regarding uses of ribose for people across all age and health categories. The company has more than 40,000 customers for its proprietary Corvalen products alone, and millions worldwide use Bioenergy ribose in other products. It is commonly found in functional foods like energy bars (Detour, FastFuel, Marathon) and beverages (SoBe Adrenaline Rush, Vitamin Water, Snapple Antioxidant Water). Currently, Bioenergy D-ribose is included as an ingredient in approximately 100 products.

In larger quantities as a Medical Food, D-Ribose also has been shown to assist patients with compromised heart function and is also widely used by patients with Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS).

Bioenergy, Inc. (http://www.bioenergy.com) is a privately held, Minneapolis-based life sciences company whose core technology lies in the development and commercialization of products based on the physiological benefits of D-ribose for health and wellness. In addition to a pharmaceutical subsidiary, Bioenergy has two other companies. Bioenergy Life Science, Inc. manufactures and sells D-ribose as an ingredient to nutraceutical firms for beverages and foods; as a medical food through doctors and clinics; and as a dietary supplement for energy recovery (reduces fatigue, muscle pain, soreness and stiffness following exercise). Viacell, LLC is developing technology related to the enhancement of blood components.


'/>"/>
SOURCE Bioenergy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Media Advisory - Atlantica BioEnergy Task Force Leaders Roundtable
2. Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production
3. BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
4. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
5. Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock
6. Raj Khankari Named Bioenergy, Inc., CEO
7. Atlantica BioEnergy Task Force Unveiled
8. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
9. BioEnergy International Facility Opens in Bay State
10. Biomaxx Systems Inc. Renews Membership With Bioenergy Australia
11. D-Ribose Helps Energy-Starved Hearts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... 2017  Kibow Biotech Inc., a pioneer in developing ... of a new patent covering a unique method for ... Patent and Trademark Office on May 23 rd ... of Bio award in 2014 in San ... approaches to chronic disease. Renadyl™, the first and only ...
(Date:6/19/2017)... NJ (PRWEB) , ... June 19, 2017 , ... ... for overseeing all service activities supporting EDETEK’s products including training, implementation, support, and ... experience to his new role. He has previously held leadership roles for service ...
(Date:6/16/2017)... ... June 16, 2017 , ... Cognition Corporation ... announced two more sessions of its “From the Helm” Webinar Series. , ... of online templates for design control exercises. Led by David Cronin, Cognition’s CEO, ...
(Date:6/15/2017)... ... June 15, 2017 , ... ... secured a Series B round of financing in the amount of $6 million. ... private investors participated in the round. , The Series B funding will enable ...
Breaking Biology Technology:
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
Breaking Biology News(10 mins):